Help accelerate Southern Research's work against COVID-19.
Learn More
On the 16th of November, 2020, Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced preliminary results for a live attenuated COVID-19 vaccine candidate engineered to express the SARS-CoV-2 (CoV-2) […]
Southern Research has named Michael Catalano and Mark Suto, Ph.D., chief operating officer and vice president for Life Sciences, respectively. Previously, Catalano served as interim COO, and Suto was VP for Drug Discovery […]
Southern Research announced an expansion of its strategic collaboration with New York-based Tonix Pharmaceuticals Holding Corp. to include a study of immune responses to SARS-CoV-2, the virus that causes COVID-19. […]
Inside a high-tech laboratory at Southern Research, a team led by Robert Bostwick, Ph.D., is screening vast numbers of compound samples to identify agents that could become a new treatment […]
Responding to the COVID-19 pandemic, Southern Research has accelerated its drug discovery and development activities to identify and test vaccines and therapeutics against coronavirus that could save lives and help […]
Southern Research Vice President of Engineering Michael D. Johns has been inducted into the State of Alabama Engineering Hall of Fame in recognition of his contributions to game-changing technologies in […]
Southern Research announced today that it has entered into a strategic collaboration with New York-based Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, to support the development of a vaccine, […]
Southern Research continues to expand its efforts to transform STEM education in schools across Alabama. The organization has revamped its STEM Ambassadors program, with an eye toward training a new […]